🟢 First Tracks Biotherapeutics is trading 6.38% up today — no confirmed company-specific catalyst found

First Tracks Biotherapeutics is trading $43.04, up 6.38% now, with no confirmed company-specific catalyst identified.

• A Wells Fargo healthcare conference presentation is scheduled for September 9, 2026; no announcement explicitly links it to the September 8 price move.
• Broader markets are lower, making market-wide sentiment an unlikely explanation for the opposite-direction move.
• No confirmed trading-volume data was found.